‌

US Patent 8513433 Small molecule inhibitors of PARP activity

Patent 8513433 was granted and assigned to Angion Biomedica Corp. on August, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Angion Biomedica Corp.

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8513433

Date of Patent

August 20, 2013

Patent Application Number

13381856

Date Filed

July 2, 2010

Patent Citations Received

‌

US Patent 11891365 3-alkyl-4-amido-bicyclic [4,5,0] hydroxamic acids as HDAC inhibitors

‌

US Patent 11702412 Bicyclic [4,6,0] hydroxamic acids as HDAC inhibitors

Patent Primary Examiner

‌

Laura L. Stockton

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8513433 Small molecule inhibitors of PARP activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API